NCT04260802 2026-01-12
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Phase 1/2 Terminated
Ocellaris Pharma, Inc.
Numab Therapeutics AG
McGill University Health Centre/Research Institute of the McGill University Health Centre
Genmab